Segments - Blood Purification Equipment Market by Type (Stationary and Portable), Application (Renal Disease, Sepsis, and Others), End-user (Hospitals & Clinics, Dialysis Centers, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global blood purification equipment market size was USD 17.17 Billion in 2022 and is likely to reach USD 27.80 Billion by 2031, expanding at a CAGR of 5.5 % during 2023–2031. The increasing prevalence of chronic diseases and blood-related disorders is expected to drive the market during the forecast period.
Blood purification equipment market is poised for growth due to the escalating demand from the global healthcare sector and the rising incidence of critical illnesses. This equipment plays a pivotal role in aiding patients experiencing difficulties in internally purifying their blood. By eliminating impurities, pathogens, and extraneous substances, the equipment ensures that the patient's blood is transfusion-ready. With chronic diseases affecting the kidneys and blood on the rise worldwide, the market is expected to witness a significant boost in the foreseeable future. For instance
In 2021, according to the data published by the Pan American Health Organization (PAHO), kidney diseases are the eighth leading cause of death, causing about 254,028 deaths across the globe in 2021.
The research report finds that the COVID-19 pandemic boosted the market. The patients affected by the coronavirus faced critical illnesses and required intensive care from hospitals to recover. According to an article published by the National Institute of Health (NIH), the virus affected the kidney function of victims, thereby causing serious renal injuries and Chronic Kidney Diseases (CKDs). Therefore, the market had a surge in demand for blood purification equipment to help patients filter blood externally. For instance,
In April 2020, the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for a blood purification system. This system is designed to treat individuals aged 18 and above who have been admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure due to COVID-19.
The use of artificial intelligence is likely to provide substantial propulsion to the blood purification equipment market. The incorporation of AI into blood purification systems is expected to enhance operational accuracy and automation. This improvement is due to AI's effective analysis of patient data, enabling personalized treatments at dialysis centers to elevate the standard of care. For instance,
On October 26, 2023, Fresenius Medical Care achieved phase-one completion of its Apollo database project, a significant milestone in AI aspirations. The largest global dataset in kidney disease care, it covers more than 540 Thousand dialysis patients, more than 140 Million treatments, and more than 34 Million lab assessments, emphasizing the crucial role of high-quality data for AI advancements at scale.
Increasing prevalence of renal diseases drives the market. People affected by kidney diseases are unable to process blood purification naturally, due to the obstruction in kidney functions. The rise in number of people suffering from chronic kidney diseases and other diseases that obstruct kidney functions is expected to boost the market during the assessment period. For instance,
On April 29, 2021, NIH data revealed a global prevalence of over 850 million individuals grappling with chronic kidney disease (CKD). This pervasive issue not only imposes a substantial healthcare and economic burden but also affects one in ten adults worldwide.
High cost of the initial equipment setting hampers the market. Blood purification equipment is costly to adopt, as they are confined to treating a certain category of diseases. The equipment requires skilled staff to operate and run maintenance tasks to ensure safety and hygiene. Therefore, the lack of skilled medical personnel to perform the procedure is another factor, likely to hinder the market growth during the forecast period.
Studies aiming to develop wearable dialysis devices for patients are expected to offer significant growth opportunities for the market in the forecast period. Patients with renal diseases typically need to visit clinics for blood purification to eliminate toxin buildup in the bloodstream. Developing reliable, user-friendly wearable devices is expected to enhance patient care, streamline operations, and generate significant market opportunities.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Blood Purification Equipment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Type (Stationary and Portable), Application (Renal Disease, Sepsis, and Others), and End-user (Hospitals & Clinics, Dialysis Centers, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Asahi Kasei Corporation; B. Braun SE; Baxter; Fresenius SE & Co. KGaA; Healthwell Medical Tech. Co., Ltd.; Infomed SA; Jafron Biomedical Co., Ltd.; KANEKA CORPORATION; Nikkiso Co., Ltd. |
Based on type, the blood purification equipment market is divided into stationary and portable. The portable segment is projected to hold the major share of the market during the projection period, as it adds to user convenience. It has a compact design that occupies only a small space in the hospital/clinic. It is easy to carry along for home dialysis treatments, as it is portable. The rising demand for portable hospital equipment is expected to drive the segment during the forecast period.
Based on application, the global market is segregated into renal disease, sepsis, and others. The renal diseases segment is projected to register a high CAGR during the forecast period, owing to the increasing prevalence of chronic diseases across the globe. Non-communicable chronic diseases such as type 1 & type 2 diabetes and high blood pressure are the leading causes of kidney-related diseases. For instance,
In September 2023, according to the data published by the World Health Organization (WHO), 2.0 million deaths of kidney disease patients occurred, caused by diabetes.
People suffering from kidney diseases such as CKD are advised to get dialysis about twice to thrice a week. The increasing life dependency of chronic kidney disease patients is anticipated to boost the market in the coming years.
Based on end-user, the blood purification equipment market is segmented into hospitals & clinics, dialysis centers, and others. The dialysis centers segment is anticipated to register a robust growth rate during the forecast period, owing to the established consumer trust in the organizations. People who suffer from renal diseases suffer from severe kidney dysfunctions. Therefore, they are required to visit the dialysis center where equipment such as a hemodialysis machine, purifies their blood, replacing the job of their kidneys. The increasing awareness regarding renal disease treatments is anticipated to boost the segment in the coming years.
In terms of region, the global blood purification equipment market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, owing to the increasing prevalence of kidney diseases in the region. For instance,
On May 30, 2023, in a report published by the CDC, CKD is the leading cause of death in the US, and about 35.5 Million of the US population are suffering from CKD.
Countries such as the US and Canada are one of the large healthcare providers across the globe, which is expected to drive the market during the assessment period.
Asia Pacific is expected to dominate the market during the projection period, owing to the progressive healthcare infrastructure in the region. Governments of developing economies such as India, China, the Philippines, and Singapore are constantly focused on making healthcare facilities increasingly accessible to patients. Furthermore, the rising prevalence of chronic diseases is expected to drive the market in the coming years.
The blood purification equipment market has been segmented based on
Key players competing in the global blood purification equipment market are Asahi Kasei Corporation; B. Braun SE; Baxter; Fresenius SE & Co. KGaA; Healthwell Medical Tech. Co., Ltd.; Infomed SA; Jafron Biomedical Co., Ltd.; KANEKA CORPORATION; Nikkiso Co., Ltd.
These companies adopted development strategies, including mergers, partnerships, collaboration, product launches, and production expansion to get an edge over the competitors. For instance,
On November 4, 2023, B. Braun SE acquired Intermedt Medizin & Technik GmbH. The company specializes in making dialysis concentrates used in hemodialysis, using ECOMix.